期刊文献+

一株产G418单组分工程菌的构建 被引量:1

Construction of an engineering strain to produce G418 single component
原文传递
导出
摘要 【目的】定向改造庆大霉素产生菌绛红小单孢菌G1008,获得产G418单组分工程菌。【方法】以温敏型穿梭质粒p KC1139为载体,构建敲除基因genQ*重组质粒p QB303,通过接合转移,导入绛红小单孢菌G1008中,影印筛选和PCR鉴定genQ*框内缺失突变菌,利用TLC和MS分析其代谢产物组分。【结果】获得一株genQ*缺失工程菌Micromonospora purpurea GQ175,其代谢产物为G418单组分,生物效价达828 mg/L,与出发菌G1008的产抗能力相当。【结论】工程菌GQ175产G418单组分,具有很好的工业开发价值。同时,证明绛红小单孢菌G1008中,庆大霉素C-6′脱氢酶基因为genQ*,且无其他同功酶基因。 [Objective] To obtain an engineering strain producing G418 single component by directional reconstruction of Micromonospora purpurea G1008 producing gentamicins. [Methods] Using the temperature-sensitive plasmid pKCl139 as vector, the recombinant plasmid pQB303 was constructed and introduced into the M. purpurea G1008 by conjugation. The genQ*-disruption mutant was screened out by replica plating and PCR analysis. Use MS and TLC for analysis of metabolites. [Results[ A genQ*-disruption strain, named as M. purpurea GQ175, was obtained to produce G418 single component. The level of antibiotic production was 828 mg/L, similar to the level of the parent strain. [Conclusion] The engineering strain GQ175 produced G418 single component, which had great value for industrial development. Collectively, these results demonstrated that the C-6' dehydrogenase gene for gentamicin biosynthesis is genQ* and there is no other isoenzyme genes in M. purpurea G1008.
出处 《微生物学通报》 CAS CSCD 北大核心 2015年第2期307-314,共8页 Microbiology China
基金 国家自然科学基金项目(No.31070093) 国家"重大新药创制"科技重大专项项目(No.2012ZX09201101-008)
关键词 绛红小单孢菌 G418 基因敲除 genQ+ Micromonospora purpurea, G418, Gene knock-out, genQ*
  • 相关文献

参考文献16

  • 1Ennifar E, Aslam MW, Strasser P, et aL Structure-guided discovery of a novel aminoglycoside conjugate targeting HIV-1 RNA viral genome[J]. ACS Chemical Biology, 2013(8):2509-2517.
  • 2DeNap JC, Thomas JR, Musk D J, et al. Combating drug-resistant bacteria: small molecule mimics of plasmid incompatibility as antiplasmid compounds[J]. American Chemical Society, 2004(126): 15402-15404.
  • 3Thomas JR, Hergenrother PJ. Targeting RNA with small molecules[J]. Chemical Society Reviews, 2008, 108(4): 1171-1224.
  • 4Vicens Q, Westhof E. Crystal structure of geneticin bound to a bacterial 16S ribosomal RNA A site oligonucleotide[J]. Journal of Molecular Biology, 2003, 326:1 175- l 188.
  • 5Waitz JA, Sabatelli F, Menzel F, et al. Biological activity of antibiotic G-418, a new Micromonospora-produced aminoglycoside with activity against Protozoa and Helminths[J]. Antimicrobal Agents and Chemotherapy, 1974, 6(5): 579-581.
  • 6Testa RT, Tilley BC. Biotransformation, a new approach to aminoglycoside biosynthesis: II. Gentamicin[J]. The Journal of Antibiotics, 1976, 29(2): 140-146.
  • 7Testa RT, Tilley BC. Biosynthesis of sisomicin and gentamicin[J]. The Japanese Journal of Antibiotics, 1979, 32: $47-$59.
  • 8Kase H, Odakura Y, Nakayama K. Sagamicin and the related aminoglycosides: fermentation and biosynthesis. I. biosynthetic studies with the blocked mutants of Micromonospora sagamiensis[J]. The Journal of Antibiotics, 1982, 35(1): 1-9.
  • 9Kudo F, Eguchi T. Biosynthetic genes for aminoglycoside antibiotics[J]. The Journal of Antibiotics, 2009(62): 471-481.
  • 10Park JW, Hong JS, Parjiuli N, et al. Genetic dissection of the biosynthetic route to gentamicin A2 by heterologous expressionof its minimal gene set[J]. Proceedings of the National Academy of Sciences, 2008, 105(5): 8399-8404.

同被引文献105

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部